Your browser doesn't support javascript.
loading
Considerations on antimicrobial prophylaxis in patients with lymphoproliferative diseases: A SEIFEM group position paper.
Busca, Alessandro; Cattaneo, Chiara; De Carolis, Elena; Nadali, Gianpaolo; Offidani, Massimo; Picardi, Marco; Candoni, Anna; Ceresoli, Eleonora; Criscuolo, Marianna; Delia, Mario; Della Pepa, Roberta; Del Principe, Ilaria; Fanci, Roma Rosa; Farina, Francesca; Fracchiolla, Nicola; Giordano, Claudia; Malagola, Michele; Marchesi, Francesco; Piedimonte, Monica; Prezioso, Lucia; Quinto, Angela Maria; Spolzino, Angelica; Tisi, Maria Chiara; Trastulli, Fabio; Trecarichi, Enrico Maria; Zappasodi, Patrizia; Tumbarello, Mario; Pagano, Livio.
Afiliação
  • Busca A; Stem Cell Transplant Center, AOU Citta' della Salute e della Scienza, Turin, Italy. Electronic address: abusca@cittadellasalute.to.it.
  • Cattaneo C; Divisione di Ematologia, ASST-Spedali Civili di Brescia, Brescia, Chiara, Italy. Electronic address: chiara.cattaneo@asst-spedalicivili.it.
  • De Carolis E; Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy. Electronic address: elena.decarolis@policlinicogemelli.it.
  • Nadali G; U.O.C. Ematologia, AOU Integrata di Verona, Ospedale Borgo Roma, Verona, Italy. Electronic address: gianpaolo.nadali@univr.it.
  • Offidani M; Clinica di Ematologia, AOU Ospedali Riuniti di Ancona, Ancona, Italy. Electronic address: massimo.offidani@ospedaliriuniti.marche.it.
  • Picardi M; Department of Advanced Biomedical Science, Federico II University, Italy. Electronic address: marco.picardi@unina.it.
  • Candoni A; Clinica Ematologica, Centro Trapianti e Terapie Cellulari, Azienda Sanitaria Universitaria Integrata di Udine, Italy. Electronic address: anna.candoni@asuiud.sanita.fvg.it.
  • Ceresoli E; Ematologia Azienda Ospedaliera San Giovanni Addolorata, Rome, Italy. Electronic address: ceresoli.eleonora@gmail.com.
  • Criscuolo M; Dipartimento di scienze radiologiche, radioterapiche ed ematologiche Fondazione Policlinico Universitario A. Gemelli IRCCS Roma, Italy. Electronic address: marianna.criscuolo@policlinicogemelli.it.
  • Delia M; U.O.: Ematologia con Trapianto Azienda Ospedaliero-Universitaria Dipartimento dell'Emergenza e Dei Trapianti di Organo Policlinico di Bari, Italy. Electronic address: mario.delia74@gmail.com.
  • Della Pepa R; Department of Clinical Medicine and Surgery", University of Federico II Naples, Italy. Electronic address: robertadellapepa@gmail.com.
  • Del Principe I; Ematologia, Dipartimento di Biomedicina e Prevenzione, Università degli studi di Roma "Tor Vergata", Italy. Electronic address: dlpmlr00@uniroma2.it.
  • Fanci RR; Hematology Department, Careggi Hospital and University of Florence, Italy. Electronic address: rosa.fanci@unifi.it.
  • Farina F; U.O. Ematologia e Trapianto di Midollo - IRCCS Ospedale San Raffaele, Milano, Italy. Electronic address: farina.francesca@hsr.it.
  • Fracchiolla N; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Italy. Electronic address: nicola.fracchiolla@policlinico.mi.it.
  • Giordano C; Department of Clinical Medicine and Surgery", University of Federico II Naples, Italy. Electronic address: claudiagiordano91@hotmail.com.
  • Malagola M; Department of Clinical and Experimental Sciences, University of Brescia, Bone Marrow Transplant Unit, ASST Spedali Civili of Brescia, Italy. Electronic address: michele.malagola@unibs.it.
  • Marchesi F; Hematology and Stem Cell Transplant Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy. Electronic address: francesco.marchesi@ifo.gov.it.
  • Piedimonte M; Department of Clinical and Molecular Medicine, Hematology Sant'Andrea University Hospital, Sapienza University of Rome, Italy. Electronic address: mpiedimonte@hotmail.it.
  • Prezioso L; Hematology and BMT Unit, Azienda Ospedaliero-Universitaria di Parma and Department of Medicine and Surgery, University of Parma, Italy. Electronic address: lprezioso@ao.pr.it.
  • Quinto AM; UO Ematologia e Terapia Cellulare, IRCCS - Istituto Tumori "Giovanni Paolo II" Bari, Italy. Electronic address: angelamaria.quinto@libero.it.
  • Spolzino A; Department of Clinical and Molecular Medicine, Hematology Sant'Andrea University Hospital, Sapienza University of Rome, Italy. Electronic address: angelica.spolzino@hotmail.it.
  • Tisi MC; Cell Therapy and Hematology, San Bortolo Hospital, Vicenza, Italy. Electronic address: mchiara.tisi@gmail.com.
  • Trastulli F; Department of Clinical Medicine and Surgery", University of Federico II Naples, Italy. Electronic address: f.trastulli@gmail.com.
  • Trecarichi EM; Dipartimento di Scienze Mediche e Chirurgiche, UO Malattie Infettive e Tropicali, Università degli Studi "Magna Graecia", Catanzaro, Italy. Electronic address: em.trecarichi@unicz.it.
  • Zappasodi P; Division of Hematology, Foundation IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy. Electronic address: P.Zappasodi@smatteo.pv.it.
  • Tumbarello M; Fondazione Policlinico Universitario A. Gemelli - IRCCS - Istituto di Malattie Infettive -Università Cattolica del Sacro Cuore, Livio, Italy. Electronic address: Mario.tumbarello@unicatt.it.
  • Pagano L; Fondazione Policlinico Universitario A. Gemelli - IRCCS - Istituto di Malattie Infettive -Università Cattolica del Sacro Cuore, Livio, Italy. Electronic address: Pagano@unicatt.it.
Crit Rev Oncol Hematol ; 158: 103203, 2021 Feb.
Article em En | MEDLINE | ID: mdl-33388453
ABSTRACT
The therapeutic armamentarium for the treatment of patients with lymphoproliferative diseases has grown considerably over the most recent years, including a large use of new immunotherapeutic agents. As a consequence, the epidemiology of infectious complications in this group of patients is poorly documented, and even more importantly, the potential benefit of antimicrobial prophylaxis remains a matter of debate when considering the harmful effect from the emergence of multidrug resistant pathogens. The present position paper is addressed to all hematologists treating patients affected by lymphoproliferative malignancies with the aim to provide clinicians with a useful tool for the prevention of bacterial, fungal and viral infections.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Linfoproliferativos / Anti-Infecciosos Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Revista: Crit Rev Oncol Hematol Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Linfoproliferativos / Anti-Infecciosos Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Revista: Crit Rev Oncol Hematol Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article